Susquehanna International Group
CTXRW

Susquehanna International Group’s Citius Pharmaceuticals, Inc. Warrant CTXRW Stock Holding History

Susquehanna International Group’s Portfolio CTXRW Stock Details CTXRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-15,871
Closed -$2K – 14821
2022
Q2 		$2K Buy
+15,871
New +$3.63K ﹤0.01% 12720
2019
Q2 		– Sell
-11,049
Closed -$3K – 11068
2019
Q1 		$3K Buy
+11,049
New +$3.06K ﹤0.01% 8684

Susquehanna International Group's CTXRW Position: Q3 2022 in Review

Susquehanna International Group sold out of Citius Pharmaceuticals, Inc. Warrant (CTXRW) in Q3 2022, closing a stake of 15,871 shares — an estimated $2K sold.

Susquehanna International Group first reported a position in CTXRW in Q1 2019 and held it in 2 quarters. The position peaked at $3K in Q1 2019. 0 funds tracked by Wall St. Rank hold CTXRW as of Q3 2022.

  • Susquehanna International Group reported no remaining Citius Pharmaceuticals, Inc. Warrant position as of Q3 2022 after selling out during the quarter.
  • Susquehanna International Group sold 15,871 Citius Pharmaceuticals, Inc. Warrant shares in Q3 2022, an estimated $2K.
  • Susquehanna International Group first reported a position in Citius Pharmaceuticals, Inc. Warrant in Q1 2019 and held it in 2 quarters.
  • Susquehanna International Group's Citius Pharmaceuticals, Inc. Warrant position peaked at $3K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Citius Pharmaceuticals, Inc. Warrant as of Q3 2022.

Based on Susquehanna International Group's 13F filing for Q3 2022, filed 14 Nov 2022.